You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
全新好(000007.SZ)獲得日本eleten株式會社頒發的《授權書》
格隆匯 12-27 21:13

格隆匯12月27日丨全新好(000007.SZ)公佈,為進一步推進產業轉型戰略,優化產業佈局,拓展公司新的盈利點和經濟增長點,增強盈利能力,實現可持續發展,公司2019129日召開第十一董事會第(臨時)會議,審議通過了《關於公司對外投資設立全資子公司的議案》,擬在控股股東的支持和幫助下,對外投資設立全資子公司“零度大健康技術(深圳)有限公司”,藉助控股股東有關優勢資源、先進技術和成熟經驗,涉足當前蓬勃興起的大健康產業,實現公司產業轉型戰略的新突破。

成立後的全資子公司零度大健康技術(深圳)有限公司將主要依據日本eleten株式會社世界專利技術——零度技術的授權,推動該技術的商業化力於大健康產業鏈的發展開啟全民預防疾病新模式

20191225,公司獲得日本eleten株式會社頒發的《授權書》,正式獲得其如下兩項世界專利技術的授權:1.納米膠囊零度分解技術2.乾式生活殺菌紙巾。

兩項專利獨家在中國境內(包括香港、澳門和台灣地區)技術推廣和使用權授權授權使用期間:20191225日至20291224日。該技術在日本主要應用在醫學和醫藥領域,全新好在中國首次應用在全民衞生大健康生活用紙領域。

該技術的作用是:它能將藥物對人體的副作用消除掉,同時保持藥物的防病滅菌功效不變,徹底消除了過去認為“是藥就有三分毒”舊觀念。公司將在明年開始在深圳和廣東地區向生活用紙領域的造紙商和經銷商提供該技術和產品,向市場推出對人體無副作用的殺菌消毒紙巾,標誌技術領先的菌“第二代”紙產品正式推出,保障人類遠離細菌,提高健康水準。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account